Tarsus Pharmaceuticals (TARS) Institutional Ownership $62.26 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$62.28 +0.02 (+0.04%) As of 05/22/2026 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tarsus Pharmaceuticals (NASDAQ:TARS)CurrentInstitutional OwnershipPercentage90.01%Number ofInstitutional Buyers(last 12 months)162TotalInstitutional Inflows(last 12 months)$634.20MNumber ofInstitutional Sellers(last 12 months)98TotalInstitutional Outflows(last 12 months)$481.41M Get TARS Insider Trade Alerts Want to know when executives and insiders are buying or selling Tarsus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data TARS Institutional Buying and Selling by Quarter Tarsus Pharmaceuticals Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026 Bank of America Corp DE1,194,377$83.79M0.0%+57.5%2.776% 5/19/2026 Janus Henderson Group PLC2,240,963$157.22M0.1%+16.1%5.209% 5/19/2026 Tri Locum Partners LP252,588$17.72M2.5%N/A0.587% 5/19/2026 Ally Bridge Group NY LLC80,859$5.67M4.6%N/A0.188% 5/18/2026 California State Teachers Retirement System37,695$2.64M0.0%+24.9%0.088% 5/18/2026 Royal Bank of Canada2,960$208K0.0%-29.7%0.007% 5/18/2026 Rock Springs Capital Management LP225,179$15.80M0.9%-13.5%0.523% 5/16/2026 The Manufacturers Life Insurance Company 37,404$2.62M0.0%-32.3%0.087% 5/16/2026 Quantinno Capital Management LP3,367$236K0.0%+22.7%0.008% 5/14/2026 Healthcare of Ontario Pension Plan Trust Fund108,800$7.63M0.0%-32.8%0.253% Get the Latest News and Ratings for TARS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/14/2026 Renaissance Technologies LLC73,400$5.15M0.0%+14.5%0.171% 5/14/2026 Gabelli Funds LLC3,600$253K0.0%N/A0.008% 5/14/2026 Pale Fire Capital SE5,652$396K0.0%+130.5%0.013% 5/14/2026 Caxton Associates LLP15,163$1.06M0.0%-63.0%0.035% 5/14/2026 Sei Investments Co.31,075$2.18M0.0%-28.3%0.072% 5/14/2026 Lido Advisors LLC24,374$1.71M0.0%N/A0.057% 5/14/2026 Walleye Capital LLC15,184$1.07M0.0%-62.3%0.035% 5/13/2026 First Trust Advisors LP122,911$8.62M0.0%+10.0%0.286% 5/8/2026 PNC Financial Services Group Inc.710$50K0.0%+367.1%0.002% 5/7/2026 Parallel Advisors LLC500$35K0.0%+139.2%0.001% 5/7/2026 Swiss National Bank62,933$4.42M0.0%+0.8%0.146% 5/6/2026 Jennison Associates LLC1,712,124$120.11M0.1%-23.2%3.980% 5/6/2026 Allspring Global Investments Holdings LLC131,612$9.24M0.0%+0.9%0.306% 5/5/2026 D.A. Davidson & CO.16,893$1.19M0.0%-7.3%0.039% 5/5/2026 Bank of New York Mellon Corp106,782$7.49M0.0%-0.9%0.248% 5/4/2026 Calamos Advisors LLC43,832$3.08M0.0%+27.3%0.102% 5/4/2026 Principal Financial Group Inc.2,855$200K0.0%N/A0.007% 5/1/2026 Fifth Third Bancorp4,923$345K0.0%N/A0.011% 4/30/2026 Hsbc Holdings PLC9,643$686K0.0%N/A0.023% 4/27/2026 Y Intercept Hong Kong Ltd11,210$786K0.0%-17.8%0.026% 4/25/2026 Strs Ohio8,800$617K0.0%+4.8%0.021% 4/25/2026 Keybank National Association OH8,838$620K0.0%-17.4%0.021% 4/24/2026 Capricorn Fund Managers Ltd26,000$1.82M0.3%+18.3%0.061% 4/22/2026 Janney Montgomery Scott LLC10,535$739K0.0%-18.2%0.025% 4/22/2026 Pictet Asset Management Holding SA38,198$2.58M0.0%+1.6%0.090% 4/20/2026 Assenagon Asset Management S.A.1,280,194$89.81M0.1%+13.5%3.008% 4/16/2026 SG Americas Securities LLC14,382$1.01M0.0%+6.4%0.034% 4/16/2026 E. Ohman J or Asset Management AB42,087$2.95M0.1%+26.3%0.099% 3/17/2026 Rockefeller Capital Management L.P.1,283$105K0.0%+15.5%0.003% 2/26/2026 Seven Fleet Capital Management LP4,500$368K0.3%N/A0.011% Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.Get the name and ticker of Louis Navellier's #1 AI stock free2/19/2026 Invesco Ltd.1,012,357$82.89M0.0%+8.0%2.385% 2/18/2026 Mackenzie Financial Corp2,454$202K0.0%N/A0.006% 2/18/2026 XTX Topco Ltd18,410$1.51M0.0%+270.3%0.043% 2/18/2026 Ikarian Capital LLC31,166$2.55M0.2%-57.7%0.073% 2/18/2026 Voloridge Investment Management LLC23,363$1.91M0.0%-60.3%0.055% 2/18/2026 Virtus Investment Advisers LLC8,399$688K0.2%-22.6%0.020% 2/18/2026 Wellington Management Group LLP16,778$1.37M0.0%-3.3%0.040% 2/18/2026 Squadron Capital Management LLC80,000$6.55M2.8%N/A0.188% 2/18/2026 Tang Capital Management LLC1,188,624$97.33M4.8%-51.6%2.800% 2/18/2026 Toronto Dominion Bank510,253$41.78M0.1%-17.4%1.202% 2/18/2026 Tudor Investment Corp ET AL22,704$1.86M0.0%N/A0.053% 2/18/2026 RTW Investments LP3,335,320$273.10M2.7%+5.0%7.857% 2/18/2026 Occudo Quantitative Strategies LP8,756$717K0.0%N/A0.021% 2/18/2026 Orbimed Advisors LLC154,400$12.64M0.3%-22.0%0.364% 2/18/2026 Odyssean LLC7,625$624K0.4%N/A0.018% 2/18/2026 Ishara Investments LP24,000$1.97M2.3%N/A0.057% 2/18/2026 Janus Henderson Group PLC1,930,325$158.06M0.1%+34.1%4.547% 2/18/2026 Engineers Gate Manager LP21,001$1.72M0.0%+229.2%0.049% 2/18/2026 Cinctive Capital Management LP28,838$2.36M0.1%N/A0.068% 2/18/2026 Cormorant Asset Management LP250,000$20.47M0.9%-16.7%0.589% 2/18/2026 Boothbay Fund Management LLC4,324$354K0.0%-64.3%0.010% 2/17/2026 Guggenheim Capital LLC3,674$301K0.0%N/A0.009% 2/17/2026 Schonfeld Strategic Advisors LLC20,674$1.69M0.0%N/A0.049% 2/17/2026 J. Goldman & Co LP2,699$221K0.0%-93.9%0.006% 2/17/2026 AQR Capital Management LLC25,919$2.12M0.0%-30.1%0.061% 2/17/2026 MPM Bioimpact LLC328,869$26.93M3.1%-3.7%0.775% 2/17/2026 Jain Global LLC9,096$745K0.0%N/A0.021% 2/17/2026 Paradigm Biocapital Advisors LP2,562,154$209.79M5.4%-3.9%6.036% 2/17/2026 Trexquant Investment LP54,546$4.47M0.0%+172.7%0.128% 2/17/2026 Jump Financial LLC128,087$10.49M0.1%-51.8%0.302% 2/17/2026 Price T Rowe Associates Inc. MD518,780$42.48M0.0%+14.6%1.222% 2/17/2026 Rock Springs Capital Management LP260,344$21.32M1.1%-9.7%0.613% 2/17/2026 Integral Health Asset Management LLC200,000$16.38M0.8%-20.0%0.471% 2/17/2026 Russell Investments Group Ltd.153,760$12.59M0.0%+3.7%0.362% 2/17/2026 State of Wisconsin Investment Board31,912$2.61M0.0%+1.1%0.075% 2/17/2026 Artisan Partners Limited Partnership436,576$35.75M0.1%-21.8%1.028% 2/17/2026 ExodusPoint Capital Management LP51,487$4.22M0.0%N/A0.121% 2/17/2026 Royal Bank of Canada4,208$344K0.0%+23.7%0.010% 2/16/2026 Squarepoint Ops LLC21,833$1.79M0.0%-73.2%0.051% 2/16/2026 Truvestments Capital LLC909$74K0.0%+106.1%0.002% 2/16/2026 Public Employees Retirement Association of Colorado4,478$367K0.0%N/A0.011% 2/16/2026 Sands Capital Alternatives LLC85,000$6.96M1.3%-50.0%0.200% 2/16/2026 Frazier Life Sciences Management L.P.728,644$59.66M1.6%-37.6%1.716% 2/16/2026 Healthcare of Ontario Pension Plan Trust Fund161,830$13.25M0.0%+61.8%0.381% 2/16/2026 Entropy Technologies LP9,396$769K0.0%N/A0.022% 2/16/2026 Barclays PLC80,784$6.62M0.0%-22.9%0.190% 2/13/2026 FORA Capital LLC8,877$727K0.1%N/A0.021% 2/13/2026 The Manufacturers Life Insurance Company 55,283$4.54M0.0%+2.4%0.130% 2/13/2026 Walleye Capital LLC40,273$3.30M0.0%+324.7%0.095% 2/13/2026 Stifel Financial Corp6,803$557K0.0%N/A0.016% The REAL Reason Trump is Invading Iran (Ad)For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.Click here to find out what it is.2/13/2026 Quarry LP2,400$197K0.0%-60.7%0.006% 2/13/2026 Morgan Stanley2,040,742$167.10M0.0%+6.7%4.807% 2/13/2026 Public Sector Pension Investment Board50,000$4.09M0.0%N/A0.118% 2/13/2026 Rafferty Asset Management LLC2,875$235K0.0%-27.8%0.007% 2/13/2026 First Trust Advisors LP111,770$9.15M0.0%+115.4%0.263% 2/13/2026 Charles Schwab Investment Management Inc.333,111$27.28M0.0%+0.1%0.785% 2/13/2026 Police & Firemen s Retirement System of New Jersey10,379$850K0.0%-6.4%0.024% 2/13/2026 State Street Corp929,059$76.07M0.0%-0.8%2.189% 2/13/2026 Vontobel Holding Ltd.8,844$724K0.0%N/A0.021% 2/13/2026 Dynamic Technology Lab Private Ltd5,160$423K0.1%N/A0.012% TARS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TARS shares? During the previous two years, 260 institutional investors and hedge funds held shares of Tarsus Pharmaceuticals. The most heavily invested institutionals were RTW Investments LP ($273.10M), Paradigm Biocapital Advisors LP ($209.79M), Vanguard Group Inc. ($196.48M), Deep Track Capital LP ($178.29M), Morgan Stanley ($167.10M), Janus Henderson Group PLC ($157.22M), and Jennison Associates LLC ($120.11M).Learn more on Tarsus Pharmaceuticals' institutional investors. What percentage of Tarsus Pharmaceuticals' stock is owned by institutional investors? 90.01% of Tarsus Pharmaceuticals' stock is owned by institutional investors. Learn more on TARS's institutional investor holdings. Which institutional investors have been buying Tarsus Pharmaceuticals' stock? Of the 230 institutional investors that purchased Tarsus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Toronto Dominion Bank ($3.82M), Assenagon Asset Management S.A. ($1.55M), Deep Track Capital LP ($1.25M), Jennison Associates LLC ($1.16M), Driehaus Capital Management LLC ($921.15K), Lord Abbett & CO. LLC ($868.46K), and Janus Henderson Group PLC ($805.96K). How much institutional buying is happening at Tarsus Pharmaceuticals? Institutional investors have bought a total of 10,035,661 shares in the last 24 months. This purchase volume represents approximately $634.20M in transactions. Which of Tarsus Pharmaceuticals' major shareholders have been selling company stock? Of the 98 institutional investors that sold Tarsus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Tang Capital Management LLC ($1.27M), Jennison Associates LLC ($917.10K), Orbimed Advisors LLC ($499.34K), Frazier Life Sciences Management L.P. ($438.88K), Paradigm Biocapital Advisors LP ($413.95K), Gilder Gagnon Howe & Co. LLC ($339.65K), and Assenagon Asset Management S.A. ($247.94K). How much institutional selling is happening at Tarsus Pharmaceuticals? Institutional investors have sold a total of 6,936,030 shares in the last 24 months. This volume of shares sold represents approximately $481.41M in transactions. Related Companies Arrowhead Pharmaceuticals Major Shareholders Elanco Animal Health Major Shareholders Cytokinetics Major Shareholders Abivax Major Shareholders Praxis Precision Medicines Major Shareholders Krystal Biotech Major Shareholders Nuvalent Major Shareholders ImmunityBio Major Shareholders Qiagen Major Shareholders Vaxcyte Major Shareholders This page (NASDAQ:TARS) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tarsus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
